David Jin

2023 - Fortress Biotech

In 2023, David Jin earned a total compensation of $1.3M as Chief Financial Officer and Head of Corporate Development at Fortress Biotech, a 15% decrease compared to previous year.

Compensation breakdown

Option Awards$582,500
Salary$400,000
Stock Awards$330,400
Other$7,333
Total$1,320,233

Jin received $582.5K in option awards, accounting for 44% of the total pay in 2023.

Jin also received $400K in salary, $330.4K in stock awards and $7.3K in other compensation.

Rankings

In 2023, David Jin's compensation ranked 903rd out of 2,910 executives tracked by ExecPay. In other words, Jin earned more than 69.0% of executives.

ClassificationRankingPercentile
All
903
out of 2,910
69th
Division
Manufacturing
534
out of 1,602
67th
Major group
Chemicals And Allied Products
361
out of 901
60th
Industry group
Drugs
350
out of 864
60th
Industry
Pharmaceutical Preparations
239
out of 622
62nd
Source: SEC filing on April 5, 2024.

Jin's colleagues

We found two more compensation records of executives who worked with David Jin at Fortress Biotech in 2023.

2023

Lindsay Rosenwald

Fortress Biotech

Chief Executive Officer

2023

Michael Weiss

Fortress Biotech

Chairman

News

You may also like